FDA updates EUA template for antigen test developers

Oct 27, 2020 - 03:12 PM
FDA-guidance

The Food and Drug Administration yesterday released an updated template for developers requesting emergency use authorization for antigen tests for the COVID-19 virus. The template adds recommendations regarding studies for antigen tests to screen asymptomatic individuals or for SAR-CoV-2 and flu. 

Related News Articles

Headline
California confirms bird flu outbreak in three dairy cow herds 
The California Department of Food and Agriculture Aug. 30 reported cows in three dairy herds tested positive for bird flu. No human cases were confirmed in…
Headline
CDC expects similar or lower number of hospitalizations in respiratory disease season outlook
The Centers for Disease Control and Prevention expects this fall and winter to have a similar or lower number of combined peak hospitalizations due to COVID-19…
Headline
FDA authorizes combination tests for flu, COVID-19
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
CDC: COVID-19 surging across the U.S.
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
CDC issues advisory on increased parvovirus B19 cases in the U.S. 
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
ASPR announces pandemic strategy to support bird flu threat to humans 
The Administration for Strategic Preparedness and Response June 25 announced a flu pandemic preparedness and response strategy in response to the threat of…